Following President Trump's historic executive order, Claritiv Health is committed to bringing FDA-approved psychedelic therapies to veterans and civilians suffering from PTSD, depression, and treatment-resistant conditions.
President Trump signed an executive order to accelerate access to psychedelic therapies for patients with serious mental illness—particularly our nation's veterans.
This landmark order directs the FDA and DEA to establish pathways for patients to access investigational psychedelic drugs—including ibogaine, psilocybin, and MDMA—that are currently under FDA review and have met basic safety requirements.
National Priority Vouchers for psychedelic drugs with Breakthrough Therapy designation, cutting red tape and accelerating review timelines.
Eligible patients can access investigational psychedelics (especially ibogaine) still under FDA review through expanded Right to Try pathways.
ARPA-H matching grants for states investing in psychedelic research programs for serious mental illness populations.
Attorney General will review successful Phase 3 clinical trials for immediate rescheduling upon FDA approval—making treatments prescribable.
We are monitoring FDA approval pathways and preparing to offer these breakthrough treatments the moment they become legally available.
We are actively preparing our clinical team, facilities, and protocols to deliver these treatments safely and effectively once approved.
At Claritiv, we recognize the unique mental health challenges faced by our nation's veterans. We're committed to making treatment accessible and affordable.
All honorably discharged veterans receive 20% off ketamine infusion therapy and all future FDA-approved psychedelic treatments. Valid military ID required.
Schedule Your ConsultationOur ketamine protocols are specifically designed for combat-related trauma and service-related PTSD.
We work closely with VA mental health providers and understand the unique challenges veterans face.
Veterans will be prioritized for new psychedelic treatments as they receive FDA approval.
While we prepare for future psychedelic therapies, ketamine infusion is FDA-approved, proven effective, and available now for immediate relief.
Ketamine infusion therapy has been shown to provide rapid relief—often within hours—for patients who haven't responded to traditional antidepressants. It's a bridge to healing while we await the next generation of psychedelic therapies.
You're not alone. Access critical mental health support and learn more about the government's psychedelic therapy initiative.
24/7 confidential support for veterans in crisis. Call 988, then press 1.
Access VA mental health care, PTSD treatment, and counseling services.
Official details on the psychedelic therapy executive order.
Learn about accessing investigational treatments under the Right to Try Act.